Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-113887
Filing Date
2025-11-19
Accepted
2025-11-19 06:23:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2529228d13_8k.htm DEFA14A 50878
2 EXHIBIT 2.2 tm2529228d13_ex2-2.htm EX-2.2 30165
3 EXHIBIT 99.1 tm2529228d13_ex99-1.htm EX-99.1 147491
  Complete submission text file 0001104659-25-113887.txt   229679
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address 10 EARLSFORT TERRACE DUBLIN 2 Ireland D02 T380 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37977 | Film No.: 251496588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)